These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO. Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272 [Abstract] [Full Text] [Related]
3. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. Knösel T, Heretsch S, Altendorf-Hofmann A, Richter P, Katenkamp K, Katenkamp D, Berndt A, Petersen I. Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377 [Abstract] [Full Text] [Related]
4. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M. Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923 [Abstract] [Full Text] [Related]
5. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma. Motoi T, Kumagai A, Tsuji K, Imamura T, Fukusato T. Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581 [Abstract] [Full Text] [Related]
6. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma. Thomas DG, Giordano TJ, Sanders D, Biermann S, Sondak VK, Trent JC, Yu D, Pollock RE, Baker L. Cancer; 2005 Feb 15; 103(4):830-8. PubMed ID: 15641030 [Abstract] [Full Text] [Related]
12. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue. Tvrdík D, Povýsil C, Svatosová J, Dundr P. Med Sci Monit; 2005 Mar 15; 11(3):MT1-7. PubMed ID: 15735574 [Abstract] [Full Text] [Related]
13. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases. Barbashina V, Benevenia J, Aviv H, Tsai J, Patterson F, Aisner S, Cohen S, Fernandes H, Skurnick J, Hameed M. J Cancer Res Clin Oncol; 2002 Nov 15; 128(11):610-6. PubMed ID: 12458341 [Abstract] [Full Text] [Related]
14. Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases. Egger JF, Coindre JM, Benhattar J, Coucke P, Guillou L. Mod Pathol; 2002 Sep 15; 15(9):998-1004. PubMed ID: 12218218 [Abstract] [Full Text] [Related]
15. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Doyle LA, Möller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. Am J Surg Pathol; 2011 May 15; 35(5):733-41. PubMed ID: 21415703 [Abstract] [Full Text] [Related]
17. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD. Mod Pathol; 2000 Nov 15; 13(11):1253-63. PubMed ID: 11106084 [Abstract] [Full Text] [Related]
18. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD, Hornick JL. Am J Surg Pathol; 2012 Oct 15; 36(10):1444-51. PubMed ID: 22982887 [Abstract] [Full Text] [Related]
19. Ossifying synovial sarcoma. Hisaoka M, Matsuyama A, Shimajiri S, Akiba J, Kusano H, Hiraoka K, Shoda T, Hashimoto H. Pathol Res Pract; 2009 Oct 15; 205(3):195-8. PubMed ID: 19041192 [Abstract] [Full Text] [Related]
20. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Kosemehmetoglu K, Vrana JA, Folpe AL. Mod Pathol; 2009 Jul 15; 22(7):872-8. PubMed ID: 19363472 [Abstract] [Full Text] [Related] Page: [Next] [New Search]